Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases
– Advancing Phase 2 and Phase 3 trials of obexelimab,
– Advancing Phase 2 and Phase 3 trials of obexelimab,
Perforator Yandex introduces Perforator, a tool that can identify and
Perforator Yandex introduces Perforator, a tool that can identify and
Report finds that internet users have passed the 5.5 billion
Marketplace Reduces Payment Integration from 18 Months to Two Weeks
LM4 Platform Brings Affordable Management Automation to IDFs and Small
LM4 Platform Brings Affordable Management Automation to IDFs and Small
LM4 Platform Brings Affordable Management Automation to IDFs and Small
LM4 Platform Brings Affordable Management Automation to IDFs and Small
Broker to showcase their capital allocation program, Axi Select, Manchester